Inpatient and emergency healthcare utilization and payments for care of SCD: an analysis of all payers in Florida 2010-2019.

ABSTRACT: Gene therapy offers transformative treatment for SCD, but access limitations necessitate continued reliance on traditional care, especially among pediatric and underserved populations. Thus, understanding healthcare utilization patterns and costs remains necessary for ongoing management and policy planning. We analyze all-payer emergency department (ED) and inpatient hospitalization data for Florida patients with SCD from 2010 to 2019. Payment estimates are constructed using novel charge-to-payment conversion methods. Outcomes are stratified by age (pediatric <12 years, adolescents 12-20 years, adults >20 years), insurance status, and income quartile. We find that ED visits for SCD increased by 95.7%, with the greatest growth among adults (106.3%). Mean ED payments rose across all age grou

SUBMITTER: Dynan L 

PROVIDER: S-EPMC12700639 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature